BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11904978)

  • 1. [Monoclonal antibody therapy for allergic asthma].
    Nishikawa M; Matsuse T
    Nihon Rinsho; 2002 Mar; 60(3):591-7. PubMed ID: 11904978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of allergic diseases with monoclonal anti-IgE antibody].
    Morita Y
    Nihon Rinsho; 2001 Oct; 59(10):2019-22. PubMed ID: 11676148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group.
    Milgrom H; Fick RB; Su JQ; Reimann JD; Bush RK; Watrous ML; Metzger WJ
    N Engl J Med; 1999 Dec; 341(26):1966-73. PubMed ID: 10607813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trials results of a unique monoclonal antibody in asthma.
    Berger WE
    Allerg Immunol (Paris); 2000 Nov; 32(9):333-5. PubMed ID: 11195855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseases.
    D'Amato G
    Eur J Pharmacol; 2006 Mar; 533(1-3):302-7. PubMed ID: 16464445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-IgE as novel therapy for the treatment of asthma.
    Fick RB
    Curr Opin Pulm Med; 1999 Jan; 5(1):76-80. PubMed ID: 10813254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of allergic bronchial asthma with omalizumab - an anti-IgE monoclonal antibody.
    D'Amato G
    Expert Opin Biol Ther; 2003 Apr; 3(2):371-6. PubMed ID: 12662149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-IgE therapy in asthma: rationale and therapeutic potential.
    Barnes PJ
    Int Arch Allergy Immunol; 2000 Nov; 123(3):196-204. PubMed ID: 11112855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-IGE therapy in asthma].
    Mehiri Ben Rhouma N; Béji M; Louzir B; Daghfous J
    Tunis Med; 2002 Oct; 80(10):575-80. PubMed ID: 12632749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human cord blood-derived mast cell responses by anti-Fc epsilon RI mAb 15/1 versus anti-IgE Omalizumab.
    Mirkina I; Schweighoffer T; Kricek F
    Immunol Lett; 2007 Apr; 109(2):120-8. PubMed ID: 17368811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-specific immunotherapy for the treatment of allergic diseases].
    Kupczyk M; Kuna P
    Pol Merkur Lekarski; 2000 May; 8(47):309-15. PubMed ID: 10944949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omalizumab: anti-IgE monoclonal antibody E25, E25, humanised anti-IgE MAb, IGE 025, monoclonal antibody E25, Olizumab, Xolair, rhuMAb-E25.
    BioDrugs; 2002; 16(5):380-6. PubMed ID: 12408744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis.
    Adelroth E; Rak S; Haahtela T; Aasand G; Rosenhall L; Zetterstrom O; Byrne A; Champain K; Thirlwell J; Cioppa GD; Sandström T
    J Allergy Clin Immunol; 2000 Aug; 106(2):253-9. PubMed ID: 10932067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-IgE monoclonal antibody (omalizumab) in the treatment of atopic asthma and allergic respiratory diseases.
    D'Amato G; Liccardi G; Noschese P; Salzillo A; D'Amato M; Cazzola M
    Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):227-9. PubMed ID: 15379589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects.
    Fahy JV; Fleming HE; Wong HH; Liu JT; Su JQ; Reimann J; Fick RB; Boushey HA
    Am J Respir Crit Care Med; 1997 Jun; 155(6):1828-34. PubMed ID: 9196082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic.
    Owen CE
    Pharmacol Ther; 2007 Jan; 113(1):121-33. PubMed ID: 17000005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-IgE therapy].
    Chazan R
    Pol Merkur Lekarski; 2003 Jun; 14(84):617-20. PubMed ID: 14524285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of anti-IgE in asthmatic subjects.
    Frew AJ
    Thorax; 1998 Aug; 53 Suppl 2(Suppl 2):S52-7. PubMed ID: 10193349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab.
    Nowak D
    Respir Med; 2006 Nov; 100(11):1907-17. PubMed ID: 16949266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response.
    Boulet LP; Chapman KR; Côté J; Kalra S; Bhagat R; Swystun VA; Laviolette M; Cleland LD; Deschesnes F; Su JQ; DeVault A; Fick RB; Cockcroft DW
    Am J Respir Crit Care Med; 1997 Jun; 155(6):1835-40. PubMed ID: 9196083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.